HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 494 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,211,718 | -5.8% | 50,673 | 0.0% | 1.90% | -10.7% |
| Q1 2023 | $5,530,451 | -4.1% | 50,673 | 0.0% | 2.12% | -10.6% |
| Q4 2022 | $5,766,587 | +83.9% | 50,673 | 0.0% | 2.37% | +47.1% |
| Q3 2022 | $3,136,000 | -22.4% | 50,673 | 0.0% | 1.61% | -24.9% |
| Q2 2022 | $4,042,000 | -24.2% | 50,673 | 0.0% | 2.15% | +20.9% |
| Q1 2022 | $5,331,000 | -2.4% | 50,673 | 0.0% | 1.78% | -1.8% |
| Q4 2021 | $5,461,000 | -1.6% | 50,673 | 0.0% | 1.81% | +8.1% |
| Q3 2021 | $5,551,000 | +17.0% | 50,673 | 0.0% | 1.67% | +50.8% |
| Q2 2021 | $4,745,000 | +1.7% | 50,673 | 0.0% | 1.11% | -17.3% |
| Q1 2021 | $4,664,000 | +25.8% | 50,673 | 0.0% | 1.34% | -11.5% |
| Q4 2020 | $3,707,000 | -5.8% | 50,673 | 0.0% | 1.52% | -33.3% |
| Q3 2020 | $3,936,000 | +39.8% | 50,673 | 0.0% | 2.27% | +21.9% |
| Q2 2020 | $2,816,000 | +87.6% | 50,673 | 0.0% | 1.87% | +35.4% |
| Q1 2020 | $1,501,000 | -58.9% | 50,673 | -49.8% | 1.38% | -47.7% |
| Q4 2019 | $3,655,000 | -50.4% | 100,973 | -62.7% | 2.63% | -59.4% |
| Q3 2019 | $7,373,000 | +13.2% | 270,775 | 0.0% | 6.49% | +85.3% |
| Q2 2019 | $6,515,000 | – | 270,775 | – | 3.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |